Alerts & Updates 25th Nov 2021
Dear Reader
The Competition Commission of India (CCI) on November 18, 2021 released its report on “Market Study on the Pharmaceutical Sector in India: Key Findings and Observations” (Study). The Study focuses on several aspects of the pharmaceutical industry including distribution channels, the role of trade associations, trade margins, online pharmacies, and the prevalence of branded generic drugs in India and their implications for competition. Given that the pharmaceutical sector is heavily regulated, the study aims to explore the areas of interface between regulation and competition with a view to ascertain CCI’s advocacy priorities.
The key focus areas identified in the study were:
Economic Laws Practice (ELP)’s Competition Law & Policy Team has prepared a brief update on CCI’s Market Study on Pharmaceutical Sector. We hope you find our update a helpful read.
As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.
